Jade Biosciences JBIO
NASDAQ JBIO
$14.12 +0.35 (+2.54%)
At close: Oct 2, 2026 · 4:00 PM EDT

Jade Biosciences (JBIO) Selling, General & Administrative (2020 - 2026)

Updated

Jade Biosciences' Selling, General & Administrative came in at $8.85 million for Q2 2026, up 69.2% from $5.23 million a year earlier and up 19.7% from the prior quarter.

Analysis

Jade Biosciences (JBIO) Selling, General & Administrative (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Jade Biosciences reported Selling, General & Administrative of $28.07 million; for FY2025, it was $20.42 million, down 4.6% from FY2024.

  • Selling, General & Administrative carries a five-year compound annual growth rate of 84.7% (FY2020 to FY2025).
  • Going back by year, Selling, General & Administrative was $21.41 million in FY2024 (+24.5%), $17.19 million in FY2023 (+17.6%), $14.62 million in FY2022 (+81.9%) and $8.04 million in FY2021 (+746.7%).
  • The Q2 2026 figure represents the highest quarterly Selling, General & Administrative in data going back to Q2 2020.
  • Year-over-year, Selling, General & Administrative increased in four of the last six quarters, with growth averaging 49.4%.
  • The fastest year-over-year change in Selling, General & Administrative over five years came in Q3 2021 (growth of 904.3%), and the weakest in Q3 2024 (a decline of 57.7%).
  • Business Quant data shows JBIO's Selling, General & Administrative at $7.39 million (Q1 2026), $6.44 million (Q4 2025) and $5.39 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 6.43 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.63 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -5.65 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.92 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 3.41 Bn
10 Jade Biosciences 897.41 Mn 897.41 Mn - 8.85 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.85 Mn
Mar 31, 2026 7.39 Mn
Dec 31, 2025 6.44 Mn
Sep 30, 2025 5.39 Mn
Jun 30, 2025 5.23 Mn
Mar 31, 2025 3.36 Mn
Dec 31, 2024 4.87 Mn
Sep 30, 2024 1.90 Mn
Jun 30, 2024 4.92 Mn
Mar 31, 2024 4.54 Mn
Dec 31, 2023 4.25 Mn
Sep 30, 2023 4.48 Mn
Jun 30, 2023 4.30 Mn
Mar 31, 2023 4.15 Mn
Dec 31, 2022 3.63 Mn
Sep 30, 2022 3.37 Mn
Jun 30, 2022 3.85 Mn
Mar 31, 2022 3.76 Mn
Dec 31, 2021 3.22 Mn
Sep 30, 2021 2.78 Mn
API Access

Jade Biosciences Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=JBIO&period=max&api_key=YOUR_API_KEY